In this connection, our data have indicated a marked and progressive decrease in Nrf2 protein levels in cortices of AD patients with the progression of the disease (Figure 8C) while the protein levels of PGC1α were slightly decreased in the Early AD (Figure 8B). This evidence concerns the gene PPARGC1A and Alzheimer disease.